"Heparin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
Descriptor ID |
D006493
|
MeSH Number(s) |
D09.698.373.400
|
Concept/Terms |
Heparin- Heparin
- Unfractionated Heparin
- Heparin, Unfractionated
- Heparinic Acid
|
Below are MeSH descriptors whose meaning is more general than "Heparin".
Below are MeSH descriptors whose meaning is more specific than "Heparin".
This graph shows the total number of publications written about "Heparin" by people in this website by year, and whether "Heparin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heparin" by people in Profiles.
-
Heparin-induced thrombocytopenia: An update for the COVID-19 era. S Afr Med J. 2021 07 20; 111(9):841-848.
-
Endogenous heparin levels in the controlled asthmatic patient. S Afr Med J. 2010 May 04; 100(5):307-8.
-
The effect of poly-L-lysine/alginate bead membrane characteristics on the absorption of heparin. Artif Cells Blood Substit Immobil Biotechnol. 2009; 37(1):13-22.
-
Efficiency of polymer beads in the removal of heparin: toward the development of a novel reactor. Artif Cells Blood Substit Immobil Biotechnol. 2006; 34(4):419-32.
-
Effects of anticoagulants and temperature on expression of activation markers CD11b and HLA-DR on human leukocytes. Clin Diagn Lab Immunol. 1998 Sep; 5(5):695-702.